Brief: Somnomed Ltd Posts Q4 FY25 Revenue Of A$30.1M
July 29 (Reuters) - Somnomed Ltd SOM.AX: Q4 FY25 REVENUE OF A$30.1M FY25 EBITDA EXPECTED TOWARDS TOP END OF A$7M-A$9M RANGE Further company coverage: SOM.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million